DK1083934T3 - Genterapifremgangsmåder - Google Patents

Genterapifremgangsmåder

Info

Publication number
DK1083934T3
DK1083934T3 DK99925174T DK99925174T DK1083934T3 DK 1083934 T3 DK1083934 T3 DK 1083934T3 DK 99925174 T DK99925174 T DK 99925174T DK 99925174 T DK99925174 T DK 99925174T DK 1083934 T3 DK1083934 T3 DK 1083934T3
Authority
DK
Denmark
Prior art keywords
gene therapy
therapy methods
methods
gene
therapy
Prior art date
Application number
DK99925174T
Other languages
Danish (da)
English (en)
Inventor
Martin Braddock
Callum Jeffrey Campbell
Jean-Luc Schwachtgen
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9811836.7A external-priority patent/GB9811836D0/en
Priority claimed from GBGB9815035.2A external-priority patent/GB9815035D0/en
Priority claimed from GBGB9819846.8A external-priority patent/GB9819846D0/en
Priority claimed from GBGB9828578.6A external-priority patent/GB9828578D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK1083934T3 publication Critical patent/DK1083934T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK99925174T 1998-06-02 1999-06-02 Genterapifremgangsmåder DK1083934T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9811836.7A GB9811836D0 (en) 1998-06-02 1998-06-02 Gene therapy method
GBGB9815035.2A GB9815035D0 (en) 1998-07-11 1998-07-11 Gene therapy method
GBGB9819846.8A GB9819846D0 (en) 1998-09-12 1998-09-12 Gene therapy method
GBGB9828578.6A GB9828578D0 (en) 1998-12-23 1998-12-23 Regulation
PCT/GB1999/001722 WO1999062561A2 (en) 1998-06-02 1999-06-02 Gene therapy method

Publications (1)

Publication Number Publication Date
DK1083934T3 true DK1083934T3 (da) 2003-12-01

Family

ID=27451790

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99925174T DK1083934T3 (da) 1998-06-02 1999-06-02 Genterapifremgangsmåder

Country Status (29)

Country Link
US (1) US6689758B1 (de)
EP (2) EP1083934B1 (de)
JP (1) JP2002516676A (de)
KR (1) KR20010043968A (de)
CN (1) CN1311822A (de)
AP (1) AP2000001999A0 (de)
AT (1) ATE246518T1 (de)
AU (1) AU770497B2 (de)
BR (1) BR9910877A (de)
CA (1) CA2334171A1 (de)
DE (1) DE69910202T2 (de)
DK (1) DK1083934T3 (de)
EA (1) EA200001124A1 (de)
EE (1) EE200000790A (de)
ES (1) ES2205830T3 (de)
HK (1) HK1034465A1 (de)
HR (1) HRP20000832A2 (de)
HU (1) HUP0103252A3 (de)
ID (1) ID27483A (de)
IL (1) IL139936A0 (de)
IS (1) IS5742A (de)
NO (1) NO20006047L (de)
NZ (1) NZ508505A (de)
PL (1) PL345207A1 (de)
PT (1) PT1083934E (de)
SK (1) SK18322000A3 (de)
TR (2) TR200100348T2 (de)
WO (1) WO1999062561A2 (de)
YU (1) YU75600A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928430D0 (en) * 1999-12-01 2000-01-26 Glaxo Group Ltd Screening
DE60321443D1 (de) * 2002-01-10 2008-07-17 Takeda Pharmaceutical Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung
CA2511315A1 (en) * 2002-12-31 2004-07-22 The Johns Hopkins University Wound healing method and kits
JPWO2005021045A1 (ja) * 2003-08-29 2006-10-26 アンジェスMg株式会社 針無注射器を用いた皮膚疾患の遺伝子治療
DE10342071B4 (de) * 2003-09-10 2006-01-19 Fleischmann, Wilhelm, Dr.med. Vorrichtung und Verfahren zur Applikation von Wïrkstoffen an eine Wundoberfläche
KR100647490B1 (ko) 2004-10-04 2006-11-23 사회복지법인 삼성생명공익재단 저산소 조건 및 다른 스트레스에 특이적으로 반응할 수있는 키메라 인핸서 요소를 포함하는 벡터, 상기 벡터를포함하는 약제학적 조성물 및 상기 조성물을 이용하는 방법
US7943591B2 (en) 2007-05-11 2011-05-17 Adynxx, Inc. Gene expression and pain
FR2920158B1 (fr) * 2007-08-24 2010-03-12 Centre Nat Rech Scient Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques
FR2924128A1 (fr) * 2007-11-26 2009-05-29 Galderma Res & Dev Modulateurs de egr1 dans le traitement de l'alopecie
EP2454368A4 (de) 2009-07-17 2013-01-09 Aaron Thomas Tabor Zusammensetzungen und verfahren zur genetischen modifizierung von zellen mit kosmetischer funktion zur verbesserung des kosmetischen erscheinungsbilds
CN102552938A (zh) * 2012-03-22 2012-07-11 南京大学 Egr-1拮抗剂在制备治疗Ⅱ型糖尿病的药物中的用途
EP2846839B1 (de) 2012-05-10 2019-02-20 Adynxx, Inc. Formulierungen zur abgabe von wirkstoffen
PT3180434T (pt) 2014-08-15 2019-10-29 Adynxx Inc Chamarizes oligonucleotídicos para o tratamento da dor
KR101721228B1 (ko) * 2015-04-03 2017-03-30 사회복지법인 삼성생명공익재단 지방유래 줄기세포의 배양액을 유효성분으로 포함하는 발모촉진용 조성물
CN104857529A (zh) * 2015-05-20 2015-08-26 山西大学 Egr-1基因在制备抗膀胱癌药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763209A (en) 1988-09-26 1998-06-09 Arch Development Corporation Methods and materials relating to the functional domains of DNA binding proteins
US5206152A (en) 1988-04-08 1993-04-27 Arch Development Corporation Cloning and expression of early growth regulatory protein genes
AUPN855496A0 (en) 1996-03-07 1996-04-04 Unisearch Limited Prevention of proliferation of vascular cells

Also Published As

Publication number Publication date
ATE246518T1 (de) 2003-08-15
AU770497B2 (en) 2004-02-26
IS5742A (is) 2000-11-28
EE200000790A (et) 2002-04-15
WO1999062561A2 (en) 1999-12-09
NO20006047L (no) 2001-02-01
AP2000001999A0 (en) 2000-12-31
ES2205830T3 (es) 2004-05-01
WO1999062561A3 (en) 2000-08-03
HUP0103252A3 (en) 2003-09-29
EP1281763A3 (de) 2003-07-09
US6689758B1 (en) 2004-02-10
EP1281763A2 (de) 2003-02-05
KR20010043968A (ko) 2001-05-25
HK1034465A1 (en) 2001-10-26
NO20006047D0 (no) 2000-11-29
DE69910202T2 (de) 2004-06-17
CA2334171A1 (en) 1999-12-09
CN1311822A (zh) 2001-09-05
AU4156099A (en) 1999-12-20
HRP20000832A2 (en) 2001-04-30
EA200001124A1 (ru) 2001-08-27
DE69910202D1 (de) 2003-09-11
PT1083934E (pt) 2003-12-31
PL345207A1 (en) 2001-12-03
NZ508505A (en) 2003-04-29
TR200100348T2 (tr) 2001-07-23
TR200102985T2 (tr) 2002-06-21
HUP0103252A2 (hu) 2001-12-28
EP1083934B1 (de) 2003-08-06
SK18322000A3 (sk) 2001-11-06
IL139936A0 (en) 2002-02-10
ID27483A (id) 2001-04-12
EP1083934A2 (de) 2001-03-21
JP2002516676A (ja) 2002-06-11
BR9910877A (pt) 2002-01-22
YU75600A (sh) 2004-03-12

Similar Documents

Publication Publication Date Title
ID27841A (id) Turunan-turunan biaril terapeutik
DE69840172D1 (de) Rna exportelement
DE69916691D1 (de) Herzschrittmacher
NO20005488D0 (no) Hematopoetisk stimulering
ID24118A (id) Terapi gabungan
DK1637127T3 (da) Terapeutisk mikroskum
DE69820860D1 (de) Herzschrittmacher
ID24275A (id) Terapi kombinasi
DE69921571D1 (de) Massagegerät
DK1083934T3 (da) Genterapifremgangsmåder
DE60016600D1 (de) Herzschrittmacher
NO20013337L (no) Ny behandling
DE59911113D1 (de) Herzschrittmacher
DE69916133D1 (de) Elektro-neuro-adaptiver stimulator
DE69836690D1 (de) Herzschrittmacher
NO20021976L (no) Selektiv leverterapi
DE60013608D1 (de) Herzschrittmacher
ID25990A (id) Susunan dna
DK0967286T3 (da) Leucinaminopeptodase-gen
DE60016452D1 (de) Herzschrittmacher
SE9803148D0 (sv) New gene
SE9803069D0 (sv) New gene
AR008310A1 (es) Metodos nuevos
SE9802023D0 (sv) New therapeutic use
ES1039862Y (es) Plantilla terapeutica